ascendis pharma glp-1 receptor agonists weight management diabetes treatments Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies ascendis pharma glp-1 receptor agonist

Available at:

Wearable devices like fitness trackers and smartwatches can supplement manual measurements, but morning resting measurements taken before activity remain the gold standard

It is essential to verify the patients understanding of the prescribed therapeutic regimen, clarify the benefits that can result from the therapy, discuss possible adverse events, and provide useful advice to minimize them, as well as simplify the therapeutic regimen when appropriate [73]

"Slowing new starts, we believe could be the result of patient warehousing as physicians await LLY's Foundayo (orforglipron) launch," Gordon wrote in a note to clients

GLP-1 RA-based treatments comply with these characteristics